Z Sun1, J Chen2, J Aakre1, R S Marks3, Y Y Garces4, R Jiang1, O Idowu5, J M Cunningham6, Y Liu7, V S Pankratz1, P Yang8. 1. Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, USA. 2. Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, USA; Department of Medical Oncology, The Second Affiliated Hospital, Dalian Medical University, Dalian; Department of Medical Oncology, The First Affiliated Hospital, China Medical University, Shenyang, People's Republic of China. 3. Department of Medical Oncology. 4. Department of Radiation Oncology, Mayo Clinic College of Medicine, Rochester, MN. 5. Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, USA; SUNY Downstate Medical Center, Brooklyn, NY. 6. Genomics Shared Resource, Mayo Clinic College of Medicine, Rochester, MN, USA. 7. Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, USA; Department of Medical Oncology, The First Affiliated Hospital, China Medical University, Shenyang, People's Republic of China. 8. Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, USA. Electronic address: yang.ping@mayo.edu.
Abstract
BACKGROUND: Small-cell lung cancer (SCLC) carries the worst prognosis among lung cancer diagnoses. Combined radiation and chemotherapy is the standard of care; however, treatment outcomes vary. Variability in the rate at which chemotherapy agents are metabolized and in the capacity of repairing DNA damage has been hypothesized to be partly responsible for the treatment response variation. Genes in the glutathione metabolism and DNA repair pathways were tested through tag single-nucleotide polymorphisms (SNPs) to assess their association with survival in SCLC. PATIENTS AND METHODS: Blood DNA from 248 patients with primary SCLC was genotyped for 419 tag SNPs from 49 genes in the glutathione and DNA repair pathways. Association analyses with patient survival were carried out at single-SNP, whole-gene, and haplotype levels after adjusting for age, gender, tumor stage, treatment modalities, and smoking history. RESULTS: Among the 375 SNPs successfully genotyped, 21 SNPs, located on 11 genes, showed significant association with survival. Whole-gene analyses confirmed 3 of the 11 genes: GSS, ABCC2, and XRCC1. Haplotype analyses of these three genes identified haplotype combinations and genomic locations underlying the observed SNP associations. CONCLUSION: Genetic variations in genes involved in the glutathione and DNA repair pathways are associated with SCLC survival.
BACKGROUND:Small-cell lung cancer (SCLC) carries the worst prognosis among lung cancer diagnoses. Combined radiation and chemotherapy is the standard of care; however, treatment outcomes vary. Variability in the rate at which chemotherapy agents are metabolized and in the capacity of repairing DNA damage has been hypothesized to be partly responsible for the treatment response variation. Genes in the glutathione metabolism and DNA repair pathways were tested through tag single-nucleotide polymorphisms (SNPs) to assess their association with survival in SCLC. PATIENTS AND METHODS: Blood DNA from 248 patients with primary SCLC was genotyped for 419 tag SNPs from 49 genes in the glutathione and DNA repair pathways. Association analyses with patient survival were carried out at single-SNP, whole-gene, and haplotype levels after adjusting for age, gender, tumor stage, treatment modalities, and smoking history. RESULTS: Among the 375 SNPs successfully genotyped, 21 SNPs, located on 11 genes, showed significant association with survival. Whole-gene analyses confirmed 3 of the 11 genes: GSS, ABCC2, and XRCC1. Haplotype analyses of these three genes identified haplotype combinations and genomic locations underlying the observed SNP associations. CONCLUSION: Genetic variations in genes involved in the glutathione and DNA repair pathways are associated with SCLC survival.
Authors: Daniel J Schaid; Charles M Rowland; David E Tines; Robert M Jacobson; Gregory A Poland Journal: Am J Hum Genet Date: 2001-12-27 Impact factor: 11.025
Authors: Zhifu Sun; Marie-Christine Aubry; Claude Deschamps; Randolph S Marks; Scott H Okuno; Brent A Williams; Hiroshi Sugimura; V Shane Pankratz; Ping Yang Journal: J Thorac Cardiovasc Surg Date: 2006-05 Impact factor: 5.209
Authors: Rafael Rosell; Lucio Crino; Kathleen Danenberg; Giorgio Scagliotti; Gerold Bepler; Miquel Taron; Vicente Alberola; Mariano Provencio; Carlos Camps; Filippo De Marinis; Jose Javier Sanchez; Ramon Peñas Journal: Semin Oncol Date: 2003-08 Impact factor: 4.929
Authors: Jun Chen; Ruoxiang Jiang; Yolanda I Garces; Aminah Jatoi; Shawn M Stoddard; Zhifu Sun; Randolph S Marks; Yunpeng Liu; Ping Yang Journal: Lung Cancer Date: 2009-06-03 Impact factor: 5.705
Authors: Wei Zhou; Sarada Gurubhagavatula; Geoffrey Liu; Sohee Park; Donna S Neuberg; John C Wain; Thomas J Lynch; Li Su; David C Christiani Journal: Clin Cancer Res Date: 2004-08-01 Impact factor: 12.531
Authors: Yafei Li; Zhifu Sun; Julie M Cunningham; Marie C Aubry; Jason A Wampfler; Gary A Croghan; Cassandra Johnson; Danli Wu; Jeremiah A Aakre; Julian Molina; Liewei Wang; V Shane Pankratz; Ping Yang Journal: Clin Cancer Res Date: 2011-06-01 Impact factor: 12.531
Authors: Jeff A Sloan; Mariza de Andrade; Paul Decker; Jason Wampfler; Curtis Oswold; Matthew Clark; Ping Yang Journal: J Clin Oncol Date: 2012-03-26 Impact factor: 44.544
Authors: V Shane Pankratz; Zhifu Sun; Jeremiah Aakre; Yan Li; Cassandra Johnson; Yolanda I Garces; Marie C Aubry; Julian R Molina; Dennis A Wigle; Ping Yang Journal: J Thorac Oncol Date: 2011-09 Impact factor: 15.609
Authors: Laura E Thomas; Jincy Winston; Ellie Rad; Matthew Mort; Kayleigh M Dodd; Andrew R Tee; Fionnuala McDyer; Stephen Moore; David N Cooper; Meena Upadhyaya Journal: Hum Genomics Date: 2015-02-15 Impact factor: 4.639